DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Astec LifeSciences Limited — Financial Results Updates

NSE 1 hr ago·31 Jul 2026, 9:55 am

Astec Lifesciences

Astec LifeSciences Limited has released its latest financial results, providing an update on its performance for the recent quarter. The company has reported its earnings, which reflect its operational activities and financial standing during this period.

For investors, these updates are important as they offer a snapshot of the company's current profitability and growth trajectory. Analyzing these figures helps stakeholders assess the company's health and make informed decisions regarding their holdings in the stock.

Investors should watch for the company's commentary on future outlook and any guidance provided regarding its strategic plans. Keeping an eye on these details will be crucial for understanding the potential direction of the stock in the coming months.